Moderate

Chronic aortic regurgitation (AR)

Valvular heart disease · Cardiac
Physician-written · Verified by three sets of doctors · Reviewed November 2026

Bedside summary

Diastolic backflow across an incompetent aortic valve causing combined volume + pressure overload and progressive LV dilatation. Tolerated for years then decompensates. Surgery is timed to LV size/function before irreversible dysfunction (contrast with acute AR, which is a surgical emergency).

Red flags

  • New dyspnoea, orthopnoea or reduced exercise tolerance (symptom onset)
  • Falling LVEF or rapidly dilating LV on serial echo
  • Features of acute AR — abrupt severe dyspnoea, hypotension (dissection/endocarditis) = emergency
  • Expanding aortic root/aneurysm
  • Fever + new/changing murmur (endocarditis)

Assessment

Differential diagnosis

  • Acute severe AR (endocarditis, dissection) — emergency, different management
  • Mixed aortic valve disease
  • Pulmonary regurgitation / other diastolic murmurs
  • High-output states causing hyperdynamic circulation
  • Dilated cardiomyopathy with functional AR

Investigations

  • Echocardiogram — regurgitation severity, LV end-systolic/diastolic dimensions, LVEF, aortic root size
  • ECG (LVH, strain), CXR (cardiomegaly, dilated aorta)
  • Cardiac MRI for regurgitant fraction/volume and LV quantification when echo equivocal
  • CT/MR aortogram if aortic root/ascending aorta dilated (esp. bicuspid, Marfan)
  • BNP/NT-proBNP; exercise testing to unmask symptoms in 'asymptomatic' patients

Management

  • Quantify AR severity and serially track LV size and LVEF
  • Identify timing-of-surgery triggers: symptoms, LVEF <=50%, LV end-systolic diameter >50 mm (or >25 mm/m2), or progressive dilatation; aortic root >=55 mm (lower in Marfan/bicuspid)
  • Control hypertension — vasodilators reduce afterload and regurgitant volume
  • Treat associated aortic root disease and consider genetic/connective-tissue evaluation if dilated root
  • Refer to Heart Team for aortic valve repair/replacement (+/- root surgery) when criteria met
  • Surveillance echo at intervals set by severity (6-12 monthly in severe)

Drugs & doses

Afterload reduction for hypertension: amlodipine 5-10 mg PO once daily, or ACEi e.g. ramipril 2.5-10 mg PO once daily [titrate]
Nifedipine or ACEi/ARB preferred to lower systolic BP and regurgitant fraction (vasodilators) [verify local choice]
Avoid bradycardia-inducing agents where possible (longer diastole increases regurgitant time) — use beta-blockers cautiously unless needed for aortic disease/Marfan
In Marfan/aortopathy: beta-blocker (e.g. bisoprolol) and/or ARB (losartan) to slow root dilatation [verify dose]
Furosemide for congestion if decompensated
Endocarditis prophylaxis is NOT routinely indicated for valve disease alone (see IE prophylaxis entry)

Disposition

Outpatient surveillance with serial echo; refer to Heart Team when surgical criteria met. Admit/urgent referral for acute AR or decompensation.

Complications & pitfalls

  • Progressive irreversible LV systolic dysfunction
  • Heart failure
  • Aortic root aneurysm and dissection
  • Infective endocarditis
  • Arrhythmia / sudden death in advanced disease

Exam pearls

  • Operate before irreversible LV damage: LVEF <=50% or LVESD >50 mm (or indexed >25 mm/m2) are key triggers even if asymptomatic (2020 AHA/ACC, 2021 ESC VHD).
  • Acute severe AR (endocarditis, dissection) is poorly tolerated and a surgical emergency — do not manage as chronic AR.
  • Vasodilator therapy helps the hypertensive AR patient but is not a substitute for timely surgery in severe AR.
  • Wide pulse pressure and the peripheral signs (Corrigan, de Musset, Quincke) reflect severity.

Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.